Innoviva is a Burlingame, California biopharmaceutical company that earns royalties on lung medicines and sells hospital critical care and antibiotic drugs. It last closed at $18.41 on Nov 20, up 0.00% on the day. The next earnings report for INVA is expected around Wed, Feb 24, 2027, after the close. For the quarter ended Sep 2026, INVA reported EPS of -$1.03 on revenue of $106.1M, with revenue down 1.6% from a year ago. Over its last 8 reports the stock moved an average of 4.2% the session after earnings.
AI Auto Pilots
Is INVA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold INVA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on INVAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
INVA · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 7% below its 20 day and 11% below its 50 day average. It is 19% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 29), oversold. The nearest support is the Pivot S1 at $18.23, and the nearest resistance the Pivot at $18.51.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 3.2%/day
Key levels
$25.1452 week high+36.6%
$21.82200 day average+18.5%
$20.88100 day average+13.4%
$20.4450 day average+11.0%
$19.7120 day average+7.1%
$19.24Swing high (Nov 16)+4.5%
$18.69Pivot R1+1.5%
$18.51Pivot+0.5%
$18.41Last close
$18.23Pivot S1−1.0%
$18.1952 week low−1.2%
Indicators
RSI (14)
29.46
Oversold below 30
Oversold
MACD
-0.68
Below its signal line
Bearish
Stochastic
6.0
Near the bottom of its range
Oversold
ADX (14)
27.4
Trending down
Williams %R
-93.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-81.1
Oversold below −100, overbought above 100
Neutral
Rate of change
−3.6%
Change over 10 sessions
Bearish
ATR (14)
$0.59
Typical daily range, 3.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 6.7%/day
Key levels
$25.1452 week high+36.6%
$21.82200 day average+18.5%
$20.88100 day average+13.4%
$20.4450 day average+11.0%
$19.7120 day average+7.1%
$19.24Swing high (Nov 16)+4.5%
$18.69Pivot R1+1.5%
$18.51Pivot+0.5%
$18.41Last close
$18.23Pivot S1−1.0%
$18.1952 week low−1.2%
Indicators
RSI (14)
33.57
Weak, oversold below 30
Neutral
MACD
-0.63
Below its signal line
Bearish
Stochastic
6.9
Near the bottom of its range
Oversold
ADX (14)
16.5
No clear trend
Williams %R
-93.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-301.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−10.9%
Change over 10 sessions
Bearish
ATR (14)
$1.23
Typical daily range, 6.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for INVA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how INVA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow INVA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for INVAHow many large options trades hit INVA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in INVA in the last 90 days.
From SEC Form 4 filings by INVA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INVA is in one of them and how their past INVA trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Innoviva
Innoviva is a biopharmaceutical company based in Burlingame, California. It earns royalties on inhaled medicines for asthma and chronic lung disease that GSK develops and sells. It also markets hospital medicines for critical care and serious bacterial infections, such as treatments for septic shock and pneumonia, which are used by hospitals and their patients. The company also holds stakes in other healthcare companies.